Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
3.580
+0.090 (2.58%)
Nov 20, 2024, 4:00 PM EST - Market closed

Mereo BioPharma Group Revenue

Mereo BioPharma Group had revenue of $1.00M in the twelve months ending September 30, 2024, down -89.64% year-over-year. In the year 2023, Mereo BioPharma Group had annual revenue of $10.00M.

Revenue (ttm)
$1.00M
Revenue Growth
-89.64%
P/S Ratio
n/a
Revenue / Employee
$30,303
Employees
33
Market Cap
554.54M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202310.00M--
Dec 31, 2022---
Dec 31, 202136.46M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Auna S.A. 1.10B
Pharming Group 285.75M
Fulgent Genetics 277.76M
SI-BONE 157.04M
Silence Therapeutics 21.77M
Opthea 261.86K
Altimmune 52.00K
Revenue Rankings